Cellyan Biotechnology Ratios (2024-2025) | HKPD

Ratios Mar2024 Sep2024 Mar2025 Sep2025
Efficiency
Assets Average (Quarter) 9.41M9.79M9.53M
Equity Average (Quarter) 4.80M5.17M5.07M
Invested Capital (Quarter) 4.43M5.59M4.99M5.48M
Leverage & Solvency
Debt to Equity (Quarter) 0.310.040.300.07
Debt Ratio (Quarter) 0.150.020.160.04
Equity Ratio (Quarter) 0.490.530.530.53
Valuation
Enterprise Value (Quarter) -0.63M-0.37M-0.75M-0.19M